Skip to main content
Print Save

Lastacaft FDA Approval History

FDA Approved: Yes (First approved July 28, 2010)
Brand name: Lastacaft
Generic name: alcaftadine
Dosage form: Ophthalmic Solution
Company: Allergan plc
Treatment for: Conjunctivitis, Allergic

Lastacaft (alcaftadine ophthalmic solution) is a topical H1 histamine receptor antagonist for eye allergy itch relief.

  • Lastacaft is available over-the-counter. Lastacaft was originally approved as a prescription medicine, but the FDA approved a complete prescription to over-the-counter (OTC) switch in December 2021.
  • Lastacaft is administered into the eyes once-daily to relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander.

Development timeline for Lastacaft

DateArticle
Mar 16, 2022Approval Now Available Over the Counter, Lastacaft Provides Eye Allergy Itch Relief in Minutes that Lasts Through 16 Hours
Jul 28, 2010Approval FDA Approves Lastacaft (alcaftadine ophthalmic solution) for Prevention of Itching Associated with Allergic Conjunctivitis

See also

Lastacaft (alcaftadine) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer